ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
AstraZeneca PLC ADS
(NY:
AZN
)
50.98
USD
+0.01 (+0.02%)
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
2,112,814
Open
50.73
Bid (Size)
50.23 (100)
Ask (Size)
51.75 (100)
Prev. Close
50.97
Today's Range
50.73 - 51.06
52wk Range
41.58 - 53.45
Shares Outstanding
1,250,000,000
Dividend Yield
3.33%
Featured News
More News
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves.
Read More
category
REGN
,
Biotechnology
,
Opinion
, and 24 more.
from
MarketWatch
Tuesday’s movers: Omthera, Tesla Motors
May 28, 2013
Shares of Omthera Pharmaceuticals shares shot up nearly 100% in premarket trade on Tuesday while Tesla Motors and Tiffany shares attracted attention.
Read More
category
Computer Software
,
OMTH
,
Oil and Gas
, and 20 more.
from
MarketWatch
Featured News
Read More
U.K.’s FTSE 100 rallies, boosted by banks, GSK
May 28, 2013
category
UK:STAN
,
HK:5
,
UK:BARC
, and 21 more.
from
MarketWatch
U.K. stocks decline, shrug off GDP data
April 25, 2013
category
VZ
,
UL
,
UK:ADM
, and 17 more.
from
MarketWatch
Stock Upgrades: High Fives for F5 Networks
April 02, 2013
category
AZN
,
DVA
,
FFIV
, and 2 more.
from
Minyanville Headlines
Stock Upgrades: Ryder on Yellow Brick Road to Riches
March 22, 2013
category
AZN
,
ADTN
,
DRI
, and 2 more.
from
Minyanville Headlines
U.K. stocks ignore strong retail data; banks off
March 21, 2013
category
HK:5
,
UK:LLOY
,
BP
, and 22 more.
from
MarketWatch
AstraZeneca slumps in weak U.K. market
January 31, 2013
category
HK:5
,
UK:BARC
,
UK:LLOY
, and 27 more.
from
MarketWatch
More News
Read More
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
category
NYSE:JNJ
,
NASDAQ:CBST
,
NYSE:PFE
, and 2 more.
from
Forbes Real Time
UPDATE 1-AstraZeneca picks site for new global home in Cambridge
June 18, 2013
category
companyNews
from
Reuters: Company News
AstraZeneca picks its new home in Cambridge next to top hospital
June 18, 2013
category
companyNews
from
Reuters: Company News
Getting Healthy with Acquisitions, New Products, and Favorable Court Rulings - Research Report on AstraZeneca, Herbalife, CardioNet, Cyberonics, and NuVasive
June 17, 2013
from
PR Newswire
BRIEF-AstraZeneca's MedImmune, NGM Biopharmaceuticals in deal to develop therapies for diabetes and obesity
June 17, 2013
category
companyNews
from
Reuters: Company News
AstraZeneca and Bristol-Myers Squibb to Present New Data at American Diabetes Association 73rd Scientific Sessions®
June 14, 2013
from
Business Wire News Releases
AstraZeneca taps outside experts to screen cancer compounds
June 13, 2013
category
companyNews
from
Reuters: Company News
Drugmakers to cooperate in safety review of diabetes drugs
June 12, 2013
category
companyNews
from
Reuters: Company News
Astrazeneca, Bristol-Myers Squibb Release Statement to American Diabetes Association
June 12, 2013
category
AZN
,
Benzinga
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
AstraZeneca and Bristol-Myers Squibb Statement on Proposal by the American Diabetes Association for Independent Review of Incretin-Based Therapies
June 12, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
See All Articles
»